Research Article
Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients
Table 2
The baseline laboratory values of both groups.
| | Variable | HCV positive
(group A)
Mean ± standard deviation | HCV negative
(group B)
Mean ± standard deviation | value |
| | WBC (cells/mm3) | 6.3 ± 2.1 | 6.2 ± 2.7 | 0.95 | | Hemoglobin (g/dL) | 12.6 ± 0.8 | 11.2 ± 1.5 | 0.03* | | Platelets (×103/mm3) | 276.9 ± 115.4 | 276.7 ± 104.3 | 0.99 | | Bilirubin (mg/dL) | 0.9 ± 0.5 | 0.8 ± 0.2 | 0.48 | | Albumin (mg/dL) | 4.0 ± 0.5 | 4.1 ± 0.4 | 0.49 | | ALT (IU/L) | 55.0 ± 30 | 37.1 ± 15 | 0.14 | | AST (IU/L) | 56.3 ± 30 | 40.6 ± 17 | 0.1 | | INR | 1.2 ± 0.3 | 1.1 ± 0.2 | 0.23 | | Creatinine (mg/dL) | 0.7 ± 0.1 | 0.8 ± 0.3 | 0.51 |
|
|
means significant ( < 0.05).
|
